泌尿系结石作为一种全球性疾病,其发病由性别、年龄、遗传因素、环境因素、饮食习惯等多种因素共同导致,其发病率和复发率呈上升趋势,因此引起全球广泛关注。近年来,结石患者的内科和外科治疗取得了重大进展,但主要是以外科治疗为主,尤其微创取石技术使大部分结石患者获益,但是成本昂贵,不适用于所有患者[1,2]。钙敏感受体(calcium- sensing receptor, CaSR) 自发现以来就被广泛关注,一项系统综述表明 CaSR基因不同部位的多态性可能与钙结石的形成有关[3]。但是尚有部分机制未阐明,也缺乏系统的阐述。本文就 CaSR的结构及其对血清钙浓度的调节和 CaSR的信号转导及其基因多态性等方面与钙性泌尿系结石发生的关系做一综述,旨在为泌尿系结石发现潜在的治疗和预防药物。
图1 CaSR 对 Ca2+的调节示意图
图2 CaSR 信号转导示意图
图3 Claudin-14 信号通路示意图
[1] Li X, Chen S, Feng D, et al. Calcium- sensing receptor promotes calcium oxalate crystal adhesion and renal injury in Wistar rats by promoting ROS production and subsequent regulation of PS ectropion, OPN, KIM- 1, and ERK expression [J]. Ren Fail, 2021,43(1):465-476.
[2] Li X, Ma J, Shi W, et al. Calcium Oxalate Induces Renal Injury through Calcium- Sensing Receptor [J]. Oxid Med Cell Longev, 2016,2016:5203801.
[3] Besiroglu H, Sahin S, Otunctemur A, et al. Calciumsensing receptor gene polymorphisms in patients with calcium urolithiasis: a systematic review [J]. Ren Fail, 2014,36(8):1187-1192.
[4] Conigrave A D, Quinn S J, Brown E M. L- amino acid sensing by the extracellular Ca2 +- sensing receptor [J].Proc Natl Acad Sci U S A, 2000,97(9):4814-4819.
[5] Kosiba A A, Wang Y, Chen D, et al. The roles of calcium- sensing receptor (CaSR) in heavy metals- induced nephrotoxicity [J]. Life Sci, 2020,242:117183.
[6] Howles S A, Wiberg A, Goldsworthy M, et al. Genetic variants of calcium and vitamin D metabolism in kidney stone disease [J]. Nat Commun, 2019,10(1):5175.
[7] Vezzoli G, Macrina L, Magni G, et al. Calcium- sensing receptor: evidence and hypothesis for its role in nephrolithiasis [J]. Urolithiasis, 2019,47(1):23-33.
[8] Jacobson H R, Seldin D W. On the generation, maintenance, and correction of metabolic alkalosis [J]. Am J Physiol, 1983,245(4):425-432.
[9] Vezzoli G, Terranegra A, Rainone F, et al. Calciumsensing receptor and calcium kidney stones [J]. J Transl Med, 2011,9:201.[10] Walker R W, Zhang S, Coleman-Barnett J A, et al. Calcium receptor signaling and citrate transport [J]. Urolithiasis, 2018,46(5):409-418.
[11] Dos Santos P M C, Amaral D, Tararthuch A L, et al. Calcium-sensing receptor (CaSR) modulates vacuolar H(+)-ATPase activity in a cell model of proximal tubule [J].Clin Exp Nephrol, 2018,22(6):1258-1265.
[12] Casare F, Milan D, Fernandez R. Stimulation of calciumsensing receptor increases biochemical H +- ATPase activity in mouse cortex and outer medullary regions [J]. Can J Physiol Pharmacol, 2014,92(3):181-188.
[13] Chen W C, Chou W H, Chu H W, et al. Thers1256328 (ALPL) and rs12654812 (RGS14) Polymorphisms are Associated with Susceptibility to Calcium Nephrolithiasis in a Taiwanese population [J]. Sci Rep, 2019,9(1):17296.
[14] Ranieri M. Renal Ca(2+) and Water Handling in Response to Calcium Sensing Receptor Signaling: Physiopathological Aspects and Role of CaSR- Regulated microRNAs [J]. Int J Mol Sci, 2019,20(21):5341.
[15] Robinson-Cohen C, Lutsey P L, Kleber M E, et al. Genetic Variants Associated with Circulating Parathyroid Hormone [J]. J Am Soc Nephrol, 2017,28(5):1553-1565.
[16] Taguchi K, Yasui T, Milliner D S, et al. Genetic Risk Factors for Idiopathic Urolithiasis: A Systematic Review of the Literature and Causal Network Analysis [J]. Eur Urol Focus, 2017,3(1):72-81.
[17] Yasui T, Okada A, Hamamoto S, et al. Pathophysiologybased treatment of urolithiasis [J]. Int J Urol, 2017,24(1):32-38.
[18] Guha M, Bankura B, Ghosh S, et al. Polymorphisms in CaSR and CLDN14 Genes Associated with Increased Risk of Kidney Stone Disease in Patients from the Eastern Part of India [J]. PLoS One, 2015,10(6):e0130790.
[19] Dimke H, Desai P, Borovac J, et al. Activation of the Ca(2 + )- sensing receptor increases renal claudin- 14 expression and urinary Ca(2+) excretion [J]. Am J Physiol Renal Physiol, 2013,304(6):761-769.
[20] Kompatscher A, De Baaij J H F, Aboudehen K, et al.Transcription factor HNF1β regulates expression of the calcium- sensing receptor in the thick ascending limb of the kidney [J]. Am J Physiol Renal Physiol, 2018,315(1):27-35.
[21] Gong Y, Renigunta V, Himmerkus N, et al. Claudin- 14 regulates renal Ca ++ transport in response to CaSR signalling via a novel microRNA pathway [J]. Embo j, 2012,31(8):1999-2012.
[22] Gong Y, Hou J. Claudin-14 underlies Ca++-sensing receptor- mediated Ca ++ metabolism via NFAT- microRNAbased mechanisms [J]. J Am Soc Nephrol, 2014,25(4):745-760.
[23] Yasri S, Wiwanitkit V. Having rs1042636C677T calciumsensing receptor polymorphism: Increased or decreased risk for nephrolithiasis? [J]. Saudi J Kidney Dis Transpl, 2018,29(3):743-744.
[24] Vezzoli G, Terranegra A, Soldati L. Calcium- sensing receptor gene polymorphisms in patients with calcium nephrolithiasis [J]. Curr Opin Nephrol Hypertens, 2012,21(4):355-361.
[25] 李勤祥,潘爱珍,徐志锋,等.CaSR986基因多态性与能谱CT泌尿系结石成分分析及临床特征的相关性[J].中国临床医学影像杂志,2020,31(02):119-122+127.
[26] Ding Q, Fan B, Shi Y, et al. Calcium- Sensing Receptor Genetic Polymorphisms and Risk of Developing Nephrolithiasis in a Chinese Population [J]. Urol Int, 2017,99(3):331-337.
[27] 谢坤,夏成兴,耿波,等.钙敏感受体(CaSR)基 986、990多态性与尿石症的相关性研究[J].现代生物医学进展,2017,17(10):1953-1956.
暂无相关信息!
暂无相关信息!
暂无相关信息!
3 CaSR 基因多态性与泌尿系结石
暂无相关信息!
暂无相关信息!
暂无相关信息!